Synthesis method of etoricoxib
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- JIANGSU TIANHE PHARMA CO LTD
- Publication Date
- 2015-06-10
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2
Abstract
Description
technical field
[0001] The invention relates to the technical field of synthesis of non-steroidal anti-inflammatory drugs, especially etoricoxib. Background technique
[0002] Etoricoxib (5-chloro-6-methyl-3[4-(methylsulfonyl)phenyl]-2,3-bipyridine), molecular formula: C 18 h 15 ClN 2 o 2 S. Etoricoxib is an important non-steroidal anti-inflammatory drug, a highly selective cyclooxygenase-2 inhibitor, and an important analgesic drug. Its performance is better than that of traditional non-steroidal anti-inflammatory drugs. It has been greatly improved, and it is the only proven coxib drug for the treatment of acute gout and arthritis, and it has become the first choice drug for the treatment of rheumatoid arthritis in my country, so the market potential is huge.
[0003] The research on the synthesis of etoricoxib at home and abroad has never stopped. At present, there are many reports on the synthesis of etoricoxib, and one of the methods is currently the method with...